Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

CHRS holding history

Coherus Oncology, Inc. in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CHRS overviewAll 13F holders of CHRSFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of CHRS by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−899,999−100.0%Sold outHolders
Q3 2025899,999$1.48M<0.1%00.0%UnchangedHolders
Q2 2025899,999$658.0K<0.1%00.0%UnchangedHolders
Q1 2025899,999$726.0K<0.1%00.0%UnchangedHolders
Q4 2024899,999$1.24M<0.1%00.0%UnchangedHolders
Q3 2024899,999$936.0K<0.1%00.0%UnchangedHolders
Q2 2024899,999$1.56M<0.1%00.0%UnchangedHolders
Q1 2024899,999$2.15M<0.1%+250,000+38.5%AddedHolders
Q4 2023649,999$2.17M<0.1%+151,400+30.4%AddedHolders
Q3 2023498,599$1.86M<0.1%+68,599+16.0%AddedHolders
Q2 2023430,000$1.84M<0.1%00.0%UnchangedHolders
Q1 2023430,000$2.94M<0.1%00.0%UnchangedHolders
Q4 2022430,000$3.41M<0.1%−591−0.1%ReducedHolders
Q3 2022430,591$4.14M<0.1%−784−0.2%ReducedHolders
Q2 2022431,375$3.12M<0.1%00.0%UnchangedHolders
Q1 2022431,375$5.57M<0.1%00.0%UnchangedHolders
Q4 2021431,375$6.88M<0.1%00.0%UnchangedHolders
Q3 2021431,375$6.93M<0.1%00.0%UnchangedHolders
Q2 2021431,375$5.97M<0.1%00.0%UnchangedHolders
Q1 2021431,375$6.30M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.